.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Chubb
Argus Health
Healthtrust
Novartis
Teva
Merck
McKinsey
Colorcon

Generated: December 18, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 06101280

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Janssen ProdsOLYSIOsimeprevir sodiumCAPSULE;ORAL205123-001Nov 22, 2013RXYesYes► Subscribe► SubscribeYYMETHOD OF TREATING HEPATITIS C
Janssen ProdsOLYSIOsimeprevir sodiumCAPSULE;ORAL205123-001Nov 22, 2013RXYesYes► Subscribe► SubscribeYMETHOD OF TREATING HEPATITIS C
Janssen ProdsOLYSIOsimeprevir sodiumCAPSULE;ORAL205123-001Nov 22, 2013RXYesYes► Subscribe► SubscribeYYMETHOD OF TREATING HEPATITIS C
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist